Blood glucose level control

Details Blood glucose level control Blood glucose level control

2006-02-28

2006-02-28

Jastrzab, Jeffrey R (Department: 3762)

Surgery: light, thermal, and electrical application

Light, thermal, and electrical application

Electrical therapeutic systems

Reexamination Certificate

active

07006871

ABSTRACT:
A pancreatic controller (102), comprising: a glucose sensor (118), for sensing a level of glucose or insulin in a body serum; at least one electrode (110, 112), for electrifying an insulin producing cell or group of cells; a power source (104) for electrifying said electrode with a pulse that does not initiate an action potential in said cell and has an effect of increasing insulin secretion; and a controller (106) which receives the sensed level and controls said power source to electrify said electrode to have a desired effect on said level.

REFERENCES:
patent: 1918386 (1933-07-01), Esau
patent: 3541390 (1970-11-01), Jahnke
patent: 3911930 (1975-10-01), Hagfors et al.
patent: 3933147 (1976-01-01), Du Vall et al.
patent: 4337776 (1982-07-01), Daly et al.
patent: 4406288 (1983-09-01), Horwinski et al.
patent: 4411268 (1983-10-01), Cox
patent: 4428366 (1984-01-01), Findl et al.
patent: 4537195 (1985-08-01), McDonnell
patent: 4537203 (1985-08-01), Machida
patent: 4554922 (1985-11-01), Prystowsky et al.
patent: 4850959 (1989-07-01), Findl
patent: 5031617 (1991-07-01), Klettner
patent: 5083564 (1992-01-01), Scherlag
patent: 5097833 (1992-03-01), Campos
patent: 5144554 (1992-09-01), Zhang et al.
patent: 5205284 (1993-04-01), Freeman
patent: 5231988 (1993-08-01), Wernicke et al.
patent: 5292344 (1994-03-01), Douglas
patent: 5320642 (1994-06-01), Scherlag
patent: 5397344 (1995-03-01), Garfield et al.
patent: 5423872 (1995-06-01), Cigaina
patent: 5447526 (1995-09-01), Karsdon
patent: 5540730 (1996-07-01), Terry, Jr. et al.
patent: 5540734 (1996-07-01), Zabara
patent: 5556760 (1996-09-01), Nakamura et al.
patent: 5741791 (1998-04-01), Olsen
patent: 5800464 (1998-09-01), Kieval
patent: 5814079 (1998-09-01), Kieval
patent: 5871506 (1999-02-01), Mower
patent: 5919216 (1999-07-01), Houben et al.
patent: 5991649 (1999-11-01), Garfield et al.
patent: 5995872 (1999-11-01), Bourgeois
patent: 6026326 (2000-02-01), Bardy
patent: 6093167 (2000-07-01), Houben et al.
patent: 6135978 (2000-10-01), Houben et al.
patent: 6261280 (2001-07-01), Houben et al.
patent: 6292693 (2001-09-01), Darvish et al.
patent: 6298268 (2001-10-01), Ben-Haim et al.
patent: 6363279 (2002-03-01), Ben-Haim et al.
patent: 6424864 (2002-07-01), Matsuura
patent: 6558345 (2003-05-01), Houben et al.
patent: 6571127 (2003-05-01), Ben-Haim et al.
patent: 6612983 (2003-09-01), Marchal
patent: 6652444 (2003-11-01), Ross
patent: 2002/0026141 (2002-02-01), Houben et al.
patent: 2003/0181958 (2003-09-01), Doubak, III
patent: 1 394 171 (1975-05-01), None
patent: 386634 (1972-08-01), None
patent: 553977 (1975-05-01), None
patent: 831131 (1979-04-01), None
patent: 2014844 (1994-06-01), None
patent: 1827793 (1995-05-01), None
patent: 2055606 (1996-03-01), None
patent: 2075980 (1997-03-01), None
patent: 2077273 (1997-04-01), None
patent: 2078547 (1997-05-01), None
patent: WO 93/02743 (1993-02-01), None
patent: WO 93/18820 (1993-09-01), None
patent: WO 94/17855 (1994-08-01), None
patent: WO 96/10358 (1996-04-01), None
patent: WO 97/15227 (1997-05-01), None
patent: WO 97/25098 (1997-07-01), None
patent: WO 97/26042 (1997-07-01), None
patent: WO 97/27900 (1997-08-01), None
patent: WO 98/10828 (1998-03-01), None
patent: WO 98/10829 (1998-03-01), None
patent: WO 98/10830 (1998-03-01), None
patent: WO 98/10831 (1998-03-01), None
patent: WO 98/10832 (1998-03-01), None
patent: WO 98/56378 (1998-12-01), None
patent: WO 98/57701 (1998-12-01), None
patent: WO 99/03533 (1999-01-01), None
Yonemura, Y. et al.; “Amelioration of Diabetes Mellitus in Partially Depancreatized Rats by Poly(ADP-Ribose) Synthetase Inhibitors. Evidence of Islet B-Cell Regeneration;” Apr. 1984; pp. 401-404; Diabetes; vol. 33; No. 4.
Holst, J.J. et al.; “Nervous Control of Pancreatic Endocrine Secretion in Pigs;” Jan. 1981; pp. 1-7; Acta Physiologica Scandinavica; vol. 111; XP000980527.
Holst, J. J. et al.; “Nervous Control of Pancreatic Endocrine Secretion in Pigs;” Jan. 1981; pp. 9-14; Acta Physiologica Scandinavica; vol. 111; XP000980528.
Parks, H. S. et al.; “Significant Cholinergic Role in Secretin-Stimulated Exocrine Secretion in Isolated Rat Pancreas;” Feb. 1998; pp. G413-G418; American Journal of Physiology; vol. 274; No. 2; Pt. 1; XP002157834.
Singh, J. et al.; “Effects of Islet Hormones on Nerve-Mediated and Acetylcholine-Evoked Secretory Responses in the Isolated Pancreas of Normal and Diabetic Rats;” Mar. 1998; pp. 627-634; International Journal of Molecular Medicine; vol. 1; No. 3; XP000980499.
Hinke, S.A. et al.; “Dipeptidyl Peptidase IV (DPIV/CD26) Degradation of Glucagon, Characterization of Glucagon Degradation Products and DPIV-Resistant Analogs;” Feb. 11, 2000; pp. 3827-3834; The Journal of Biological Chemistry 2000; vol. 275; No. 6.
Wright, L. M. et al.; “Stracture of Fab hGR-2 F6, a Competitive Antagonist of the Glucagon Receptor;” May 2000; pp. 573-580; Acta Crystallographica Section D Biological Crystallography; vol. 56 (pt 1).
Meurer, J. A. et al.; “Properties of Native and In Vitro Glycosylated Forms of the Glucagon Like Peptide-1 Receptor Antagonist Extendin(9-39);” Jun. 1999; pp. 716-724; Metabolism; vol. 48; No. 6.
Wang, F. et al.; “Islet Amyloid Polypeptide Tonally Inhibits -, -, and -Cell Secretion is Osolated Rat Pancreatic Islets;” Jan. 1999; pp. E19-E24; American Journal of Physiology; vol. 276 (1 pt 1).
Ohinata, K. et al.; “Proadrenomedullin N-Terminal 20 Peptide (PAMP) Elevates Blood Glucose Levels Via Bombesin Receptor in Mice;” May 12, 2000; pp. 207-211; FEBS Letters; vol. 473; No. 2.
Shah, P. et al.; Impact of Lack of Suppression of Glucagon on Glucose Tolerance in Humans; Aug. 1999; pp. E283-E290; American Journal of Physiology; vol. 277 (2 pt 1).
Liu, S. et al.; “2-Pyridylthioureas Novel Nonpeptide Somatostatin Agonist with SST4 Selectivity;” Apr. 1999; pp. 255-263; Current Pharmaceutical Design; vol. 5; No. 4.
Bouaziz, A. et al.; “Direct Electrical Stimulation of Insulin Secretion by Intact Murine Islets of Langerhans Through the Culture Support;” 1998; pp. 171-184; Electro- and Magnetobiology; vol. 17; No. 2.
Misler, S. et al.; “Electrophysiology of Stimulus-Secretion Coupling in Human b-Cells;” Oct. 1992; pp. 1221-1228; Diabetes; vol. 41.
Gold, G. et al.; Evidence that Glucose “Marks” b Cells Resulting in Preferential Release of Newly Synthesized Insulin; 1 Oct. 1982; pp. 56-58; Science; vol. 218.
Kurose, T. et al.; “Glucagon, Insulin and Somatostatin Secretion in Response to Sympathetic Neural Activation in Streptozotocin-Induced Diabetic Rats. A Study with the Isolated Perfused Rat Pancreas In Vitro;” 1992; pp. 1035-1041; Diabetologia; vol. 35.
Rivera, V. M. et al.; “Regulation of Protein Secretion Through Controlled Aggregation in the Endoplasmic Reticulum;” Feb. 4, 2000; pp. 826-830; Science; vol. 287.
Davis, S. N. et al.; “Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas;” The Pharmacological Basis of Therapeutics; Chapter 60; pp. 1487-1499; pp. 1507-1510; edited by Hardman, J. G. et al.
Bergsten, P. et al.; “Synchronous Oscillations of Cytoplasmic Ca2+ and Insulin Release in Glucose-Stimulated Pancreatic Islets;” Mar. 1994; pp. 8749-8753; The Journal of Biological Chemistry; vol. 269; No. 12.
Palti, Y. et al.; “Islets of Langerhans Generate Wavelike Electric Activity Modulated by Glucose Concentration;” May 1996; pp. 595-601; Diabetes; vol. 45.
Kuffler, S. W. et al.; “Release of Chemical Transmitters;” Chapter 10; pp. 241-261; From Neuron to Brain, a Cellular Approach to the Function of the Nervous System; Second Edition; Sinauer Associates Inc. Publishers; Sunderland, Massachusetts.
Serre, V. et al.; “Exendin(9-39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3′,5′-Monophosphate Levels and B-Cell Glucose Competence;” N

Affiliated with

Also associated with

Rating

Blood glucose level control does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blood glucose level control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood glucose level control will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3638124